Where conviction is rising: AI software, crypto rails, and new design tools
The biggest adds cluster around three themes: AI-native software, fintech/crypto infrastructure, and design/productivity platforms.
On the software side, ARK is leaning into companies that monetize AI workflows directly rather than just selling GPUs. Tempus AI is a major add (up 27.1% in shares), while CoreWeave and Roblox see sizeable increases, signaling a preference for compute orchestration, vertical AI, and engagement platforms over generic cloud.
In fintech, they are pushing chips forward on Robinhood (shares up 24.9%), Circle Internet Group (up 8.9%), and Bullish (up 36.1%), even though Circle and Bullish sit deep in the red versus average cost. That is a classic ARK tell: they are buying the crypto and trading-rail shakeout, not selling it.
The surprise is the scale-up in Figma (shares up 483.2%), plus a fresh entry into Broadcom at 0.98% of the book. Together with bigger stakes in Alphabet and Shopify, this says they see durable demand for AI-infused productivity and design tools, and want exposure to the more recurring, software-like parts of the AI stack.
Conviction
The big buys
The biggest dollar adds this quarter β where conviction is rising.
| Position | Change | Portfolio weight | Value |
|---|---|---|---|
| AVGOBroadcom Inc | New+$126.2M | 1.0% | $126.2M |
| TEMTempus AI Inc | Added 27.1%+$92.7M | 3.4% | $434.5M |
| HOODRobinhood Markets Inc | Added 24.9%+$82.9M | 3.2% | $416.0M |
| BLSHBullish | Added 36.1%+$62.2M | 1.8% | $234.5M |
| RBLXROBLOX Corp | Added 22.0%+$60.1M | 2.6% | $333.5M |
| FIGFigma Inc | Added 483.2%+$59.4M | 0.6% | $71.7M |
| GOOGAlphabet Inc | Added 32.0%+$50.1M | 1.6% | $206.7M |
| CRWVCoreWeave Inc | Added 31.9%+$47.6M | 1.5% | $196.6M |
Dollar changes estimated at current prices (shares added Γ current price); top-50 current positions only.
What theyβre trimming: taking profits in crowded winners to feed new risk
Funding sources this quarter are clear: ARK is pulling capital out of AI winners that have already repriced and out of mature genomics platforms, then recycling into earlier-stage upside.
The biggest single cash register is Teradyne, with the position cut 47.2% by shares. Roku is down 35.0%, Meta down 48.4%, and Tesla trimmed 2.9% β all sizeable winners versus cost β which looks more like risk-budgeting than a thesis abandonment.
In semis, Nvidia is cut 17.5% and Taiwan Semi 16.1%, even as they open Broadcom, effectively rotating within the capex cycle from pure GPU scarcity into broader diversified chip exposure. Health care trims β notably Twist Bioscience, Illumina, Natera, and Veracyte β indicate a conscious pivot away from genomics and lab tooling in favor of higher-upside therapeutics and platform biology (they add to CRISPR Therapeutics, Intellia, and Recursion instead).
Sector rotation: out of industrial hardware, into software, finance, and defense
The sector bars tell you ARK isnβt backing off risk; itβs redirecting it. Technology climbs from 30.59% to 33.67% of the book, while Industrials falls from 29.31% to 26.92% and Health Care dips from 17.11% to 16.3%.
Within Technology, the mix is shifting from megacap platforms and commodity semis toward application software, developer tooling, and AI-native services. Adds in Tempus AI, Figma, Roblox, CoreWeave, Shopify, DoorDash, and Toast outweigh trims in Meta, Block, and some semis, leaving the sector more idiosyncratic and less FAANG-dependent.
Finance jumps from 13.9% to 15.29%, driven by Robinhood, Circle, Bullish, BitMine, and incremental SoFi positioning. Meanwhile, Industrials is being reshaped rather than abandoned: they are taking some money out of machinery (Deere, Trimble, BWX) and test equipment (Teradyne) and loading up on advanced defense and aerospace names like L3Harris, AeroVironment, Joby, Archer, Rocket Lab, Elbit, and Intuitive Machines.
What this portfolio says about ARKβs next act
Taken together, this is ARK doubling down on its core identity: early in controversial, high-beta innovation, late to capitulate on drawdowns. The average mark-to-cost on several of their biggest adds β Circle, Bullish, Recursion, Figma, GeneDx, BitMine, Archer, Joby β is deeply negative, yet they are increasing exposure, effectively calling a bottom in the more speculative edges of AI, genomics, and crypto.
At the same time, the trims in Nvidia, Taiwan Semi, Meta, Roku, Teradyne, Twist, Illumina, and Tesla show a new discipline around crowded winners and hardware-heavy stories. They are redirecting that risk into software leverage, financial infrastructure, and dual-use defense platforms that can monetize AI and autonomy over a full cycle.
Going forward, expect this book to behave less like a bet on βAI leadersβ and more like a leveraged play on the second and third derivatives of AI adoption β the rails, tools, and specialized platforms that either become monopolistic or go to zero. ARK is clearly comfortable with that distribution; the quarterβs -11.3% print did not push them toward safety, it pushed them deeper into where they think the next 5β10 years of growth live.
Frequently asked questions
What did ARK Investment Management LLC buy in 2026-Q1?+
In 2026-Q1, ARK ramped positions in Tempus AI, Robinhood, Bullish, Roblox, Figma, Alphabet, CoreWeave, and several aerospace and defense names, and initiated a new stake in Broadcom.
What is ARK Investment Management LLC's biggest holding in the 2026-Q1 filing?+
As of the 2026-Q1 13F, Tesla is ARKβs largest disclosed position at 8.19% of the reported portfolio value.
How did ARK Investment Management LLC change its AI exposure this quarter?+
ARK trimmed Nvidia, Taiwan Semiconductor, Meta, and Roku while adding to Tempus AI, CoreWeave, Figma, Alphabet, and Shopify, shifting from early AI hardware and megacaps toward AI-native software and infrastructure.
Is ARK Investment Management LLC increasing or decreasing its crypto and fintech exposure?+
ARK increased stakes in Robinhood, Circle Internet Group, Bullish, BitMine, and modestly in SoFi, raising its Finance sector weight from 13.9% to 15.29% and signaling higher conviction in crypto and trading rails.
How is ARK Investment Management LLC positioned in health care and genomics?+
ARK trimmed genomics and diagnostics platforms like Twist Bioscience, Illumina, Natera, and Veracyte, while adding to CRISPR Therapeutics, Intellia, Recursion, and maintaining Beam, emphasizing therapeutic and platform biology over lab infrastructure.
Did ARK Investment Management LLC de-risk after its negative 2026-Q1 performance?+
Despite a reported -11.3% quarter, ARK kept overall concentration high and rotated from crowded winners into higher-volatility AI software, fintech, crypto, and advanced defense names, indicating a shift in focus rather than a broad de-risking.